Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy.
Caravaca-Fontán F, Cavero T, Díaz-Encarnación M, Cabello V, Ariceta G, Quintana LF, Marco H, Barros X, Ramos N, Rodríguez-Mendiola N, Cruz S, Fernández-Juárez G, Rodríguez A, Pérez de José A, Rabasco C, Rodado R, Fernández L, Pérez-Gómez V, Ávila A, Bravo L, Espinosa N, Allende N, Sanchez de la Nieta MD, Rodríguez E, Rivas B, Melgosa M, Huerta A, Miquel R, Mon C, Fraga G, de Lorenzo A, Draibe J, González F, Shabaka A, López-Rubio ME, Fenollosa MÁ, Martín-Penagos L, Da Silva I, Titos JA, Rodríguez de Córdoba S, Goicoechea de Jorge E, Praga M; Spanish Group for the Study of Glomerular Diseases (GLOSEN).
Caravaca-Fontán F, et al.
Kidney360. 2023 May 1;4(5):659-672. doi: 10.34067/KID.0000000000000115. Epub 2023 Mar 30.
Kidney360. 2023.
PMID: 36996481
Free PMC article.
KEY POINTS: Kidney survival in C3 glomerulopathy is significantly higher in patients with a disease chronicity score <4 and proteinuria <3.5 g/d, regardless of baseline eGFR. A faster eGFR decline in C3 glomerulopathy is associated with higher probability of k …
KEY POINTS: Kidney survival in C3 glomerulopathy is significantly higher in patients with a disease chronicity score <4 and protei …